Literature DB >> 22103838

Nef surfaces: where to interfere with function.

Sebastian Lulf1, Florian A Horenkamp, Sebastian Breuer, Matthias Geyer.   

Abstract

The HIV-1 Nef protein is an accessory protein of 24-27 kDa mass that mediates a multitude of effector functions in infected cells. Although not essentially required for viral replication, HIV-1 Nef exhibits stimulating potential towards disease progression to AIDS and is therefore considered a pathogenic factor in retroviridae. Here we correlate sequence conservation in HIV-1 Nef with surface hydrophobicity and functionality in protein-protein interaction to identify accessible substructures on the surface of Nef that might be suitable as pharmacological target sites. Recent advances in targeting of Nef by small molecular compounds that interfere with SH3 domain binding or MHC class I down-regulation are discussed. Similarly, approaches for the use of larger molecules are introduced, such as tailored fusion proteins that simultaneously interact with multiple highly conserved sequence motifs of Nef. In addition, the design of a single domain antibody from llama that interferes with CD4 down-regulation activity and PAK2 binding is discussed. The flexibility in binding recognition is exemplarily shown for the modulation of RT-loop binding using engineered SH3 domains. The various considerations corroborate the potential of HIV-1 Nef as a promising target for the development of potent Nef inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103838     DOI: 10.2174/157016211798842053

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  4 in total

1.  A Biochemical/Biophysical Assay Dyad for HTS-Compatible Triaging of Inhibitors of the HIV-1 Nef/Hck SH3 Interaction.

Authors:  Sebastian Breuer; Sheryll Espinola; Xavier Morelli; Bruce E Torbett; Stefan T Arold; Ingo H Engels
Journal:  Curr Chem Genom Transl Med       Date:  2013-07-26

2.  Endocytic sorting motif interactions involved in Nef-mediated downmodulation of CD4 and CD3.

Authors:  Santiago Manrique; Daniel Sauter; Florian A Horenkamp; Sebastian Lülf; Hangxing Yu; Dominik Hotter; Kanchan Anand; Frank Kirchhoff; Matthias Geyer
Journal:  Nat Commun       Date:  2017-09-05       Impact factor: 14.919

3.  Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody.

Authors:  Sebastian Lülf; Julie Matz; Marie-Christine Rouyez; Annika Järviluoma; Kalle Saksela; Serge Benichou; Matthias Geyer
Journal:  Retrovirology       Date:  2014-03-13       Impact factor: 4.602

4.  Link between primate lentiviral coreceptor usage and Nef function.

Authors:  Jan Schmökel; Hui Li; Asma Shabir; Hangxing Yu; Matthias Geyer; Guido Silvestri; Donald L Sodora; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Rep       Date:  2013-11-21       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.